Showing results (21-30 of 706) with videos related to
Sort By:
Pageof 71
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Current approaches to the management of bladder cancer in older patientsKristian D Stensland, Matthew D GalskyExpert Review of Anticancer Therapy|February 27, 2025
An evaluation of nivolumab plus gemcitabine and cisplatin in the treatment of advanced urothelial carcinomaEric J Miller, Matthew D GalskyClinical Advances in Hematology & Oncology : H&O|April 20, 2013
Advances in the management of muscle-invasive bladder cancer through risk prediction, risk communication, and novel treatment approachesMatthew D Galsky, Josep Domingo-DomenechCancer Treatment Reviews|March 18, 2014
Safety and efficacy of addition of VEGFR and EGFR-family oral small-molecule tyrosine kinase inhibitors to cytotoxic chemotherapy in solid cancers: a systematic review and meta-analysis of randomized controlled trialsTomohiro Funakoshi, Asma Latif, Matthew D GalskyCancer|March 8, 2021
The impact of the globalization of cancer clinical trials on the enrollment of Black patientsSerena Tharakan, Xiaobo Zhong, Matthew D GalskyCancer Treatment Reviews|March 5, 2013
Risk of hematologic toxicities in cancer patients treated with sunitinib: a systematic review and meta-analysisTomohiro Funakoshi, Asma Latif, Matthew D GalskyCritical Reviews in Oncology/Hematology|July 9, 2013
Risk of hematologic toxicities in patients with solid tumors treated with everolimus: a systematic review and meta-analysisTomohiro Funakoshi, Asma Latif, Matthew D GalskyExpert Review of Anticancer Therapy|May 22, 2020
Urothelial carcinoma: the development of FGFR inhibitors in combination with immune checkpoint inhibitorsQian Qin, Vaibhav Patel, Matthew D GalskyClinical Genitourinary Cancer|January 24, 2007
Targeting growth factor and antiangiogenic pathways in clear-cell renal cell carcinoma: rationale and ongoing trialsThomas E Hutson, Guru Sonpavde, Matthew D GalskyCancer Treatment and Research|September 1, 2018
Current Role of Checkpoint Inhibitors in Urologic CancersKyrollis Attalla, John P Sfakianos, Matthew D GalskyPageof 71